MediGene AG

FRA:MDG1 ISIN:DE000A161NA3

Medigene AGMedigene AG (FRA:MDG1) is a biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies.

 
   
 

View in Other Languages

News

MediGene AG; New Clinical Data For EndoTAG(TM)-1 To Be Presented At

🕔9/9/2008 4:33:02 PM 2234

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article
###

13,356 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 21) (Last 30 Days: 98) (Since Published: 8837) 

Company Data

    Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.medigene.com

Social Media